Seoul, South Korea

Eun-Young Choi

USPTO Granted Patents = 16 


 

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 67(Granted Patents)


Location History:

  • Kyunggi-do, KR (2003)
  • Gyeonggi-do, KR (2007 - 2009)
  • Suwon-si, KR (2010 - 2013)
  • Seoul, KR (2006 - 2024)

Company Filing History:


Years Active: 2003-2024

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Eun-Young Choi: Innovator in Chimeric Antigen Receptor Technology

Introduction

Eun-Young Choi is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of immunotherapy, particularly through his innovative work on chimeric antigen receptors (CARs). With a total of 16 patents to his name, Choi's inventions are paving the way for advancements in cancer treatment.

Latest Patents

One of Choi's latest patents is the "Immune synapse-stabilizing chimeric antigen receptor (CAR) T cell." This invention relates to a novel chimeric antigen receptor that includes a CD99 region, which plays a crucial role in stabilizing immune synapses. The CD99-based CAR-T cells are capable of forming stable immune synapses with tumor cells, leading to improved therapeutic efficiency in cancer treatment. Another significant patent is focused on the "Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof." This invention pertains to a CD43 epitope expressed on human acute leukemia and lymphoblastic lymphoma cells, which can be utilized for diagnostic and therapeutic applications.

Career Highlights

Choi has worked with notable companies such as Samsung Electronics Co., Ltd. and Dinona Inc. His experience in these organizations has contributed to his expertise in developing cutting-edge technologies in the field of immunotherapy.

Collaborations

Choi has collaborated with several professionals in his field, including Seong-Hoe Park and Kyeong-Cheon Jung. These collaborations have further enhanced his research and development efforts.

Conclusion

Eun-Young Choi's innovative work in the field of chimeric antigen receptors is making a significant impact on cancer therapy. His patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…